[1]
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li Y., Wang X., Zhao, L. Inflammatory responses and inflammation-associated diseases in organs, Oncotarget, (2018) 9(6), 7204–7218.
DOI: 10.18632/oncotarget.23208
Google Scholar
[2]
FitzGerald G.A., Coxibs and cardiovascular diseases, N. Eng. J. Med. (2004) 351, 1709-1711.
Google Scholar
[3]
Mitchell J.A., Warner T.D., COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Nat. Rev. Drug Discov., (2006) 75-86.
DOI: 10.1038/nrd1929
Google Scholar
[4]
Bishop-Bailey D., Mitchell J.A., Warner T.D., COX-2 in Cardiovascular Disease. (2006) 26:956–958.
Google Scholar
[5]
Majed, B. H., & Khalil, R. A. (2012). Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacological reviews, 64(3), 540–582.
DOI: 10.1124/pr.111.004770
Google Scholar
[6]
Elvira E., Josep Q. R., Xavier G., Antoni B. M., and Rosa M. L., (2019) In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice. Journal of Natural Products 82 (2), 177-182.
DOI: 10.1021/acs.jnatprod.8b00366
Google Scholar
[7]
Hosseinzade, A., Sadeghi, O., Naghdipour Biregani, A., Soukhtehzari, S., Brandt, G. S., & Esmaillzadeh, A. (2019). Immunomodulatory Effects of Flavonoids: Possible Induction of T CD4+ Regulatory Cells Through Suppression of mTOR Pathway Signaling Activity Frontiers in immunology, 10, 51.
DOI: 10.3389/fimmu.2019.00051
Google Scholar
[8]
Lee H.H, Moon Y.H, Shin J.S, Lee J.H, Kim T.W, Jang C.Y, Park C., Lee J., Kim Y., Kim Y., Werz O., Park B.Y, Lee J.Y, Lee K.T, (2019) A novel mPGES-1 inhibitor alleviates inflammatory responses by downregulating PGE2 in experimental models, Prostaglandins & Other Lipid Mediators,144, 1098-8823.
DOI: 10.1016/j.prostaglandins.2019.106347
Google Scholar
[9]
Rullah K., Aluwi M.F.F.M, Yamin B. M., Bahari M. N. A., Wei L. S., Ahmad S., Abas F., Ismail N. H., Jantan I., Wai L. K. (2014) Inhibition of prostaglandin E2 production by synthetic minor prenylated chalcones and flavonoids: Synthesis, biological activity, crystal structure, and in silico evaluation, Bioorganic & Medicinal Chemistry Letters, 24 (16), 3826-3834.
DOI: 10.1016/j.bmcl.2014.06.061
Google Scholar
[10]
Luz J.G. , Antonysamy S., Kuklish S.L., Condon B., Lee M.R., Allison D., Yu X.P., Chandrasekhar S., Backer R., Zhang A., Russell M., Chang S.S., Harvey A., Sloan A.V., Fisher M.J., (2015). Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics. Journal of Medicinal Chemistry. 58(11), 4727-37.
DOI: 10.1021/acs.jmedchem.5b00330
Google Scholar